Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  12/15/2011
 
Trade Name:  Nexium
 
Generic Name or Proper Name (*):  esomeprazole
 
Indications Studied:  Erosive esophagitis due to acid-mediated gastroesophageal reflux disease
 
Label Changes Summary:  Expanded age range to include pediatric patients 1 month to <1 year. Previously approved in 1-17 years. Use in 1 month to <1 year is supported by extrapolation of studies for adults and safety, pharmacokinetic, and pharmacodynamic studies performed in pediatric patients Safety and effectiveness have not been established in neonatesInformation on weight-based dosing, adverse reactions, clinical study
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B) and PREA(P):  B, P
 
Sponsor:  AstraZeneca
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiulcerative
 
-
-